Newsletter | September 22, 2026

09.22.26 -- How Clinical Supply Teams Can Prevent Cross-Border Shipping Delays

FEATURED EDITORIAL

Root Causes, Part 1: When Trial Design Locks In Supply Risk

This first installment of our new Root Causes video series examines how decisions made long before execution can shape clinical supply outcomes.

 

The Silent Threat To Clinical Trials: Why Shelf-Life Management Can Determine Study Success

Shelf life is more than an expiration date. Explore how global trials can turn aging inventory into supply disruptions, added costs, and risks to patient treatment.

 

AI Is Only As Good As The Data Behind Your Clinical Trial Supply Chain

AI cannot fix bad clinical supply data. Disconnected systems, conflicting inventory and manual workarounds can turn smart forecasting into costly mistakes.

 

SOLUTIONS

Specialized Support For Clinical Supplies

MORE GREAT EDITORIAL

6 Risks To Clinical Supply Spurred By 'Once In A Lifetime' Lp(a) Screening

Expert-recommended "once‑in‑a‑lifetime" testing for Lp(a) introduces new clinical supply risks as screening drives volatility, longer treatment, and inventory strain.

Bridging Clinical Operations And Supply Chain: Aligning Execution In High-Stakes Trials

Small disconnects between clinical ops and supply chain can derail complex trials. Strong alignment keeps forecasts accurate, supply on track, and patients supported.

How Clinical Supply Teams Can Prevent Cross-Border Shipping Delays

Avoid costly delays in global clinical trials by mastering regulatory compliance, coordinating logistics, and using tech to keep investigational therapies on schedule.